Mesenchymal stem cells (MSCs) are a promising cell resource for tissue engineering. Sry‐
related high‐mobility group box 11 (Sox11) plays critical roles in neural development and …

Postmenopausal osteoporosis (PMOP) is a common systemic skeletal disease
characterized by reduced bone mass and microarchitecture deterioration. Although …

Background: Mesenchymal stem cells (MSC) are promising tools for tissue-engineering and
musculoskeletal regeneration. They reside within various tissues, like adipose tissue …

Bone morphogenetic protein 2 (BMP2) is one of the key chondrogenic growth factors
involved in the cartilage regeneration. However, it also exhibits osteogenic abilities and …

As a profoundly anabolic regulator of bone, Wnt7b is well acknowledged to enhance
osteoblast activities. Here, we report that bone marrow mesenchymal stem cells (BMSCs) …

Mesenchymal stem cells (MSCs) have several features that make them an attractive option
for potentiating cartilage repair. Synovium-derived (SMSCs) have been recently recognized …

Cartilage injuries caused by arthritis or trauma pose formidable challenges for effective
clinical management due to the limited intrinsic proliferative capability of chondrocytes …

Sox9 is a key transcription factor in early chondrogenesis with distinct roles in differentiation
processes and during embryonic development. Here, we report that Sox9 modulates cell …

Introduction: Runx2 is one of the most studied transcription factors expressed in
mesenchymal stem cells (MSCs) upon their commitment toward an osteogenic …

Mesenchymal stem cells (MSCs) are a reliable cell source for tissue regeneration. However,
the molecular mechanisms underlying the directed differentiation of MSCs remain unclear; …